Objective: Dysfunction of the central dopaminergic neurotransmission has been suggested to play an important role in the etiology of schizophrenia. The dopamine transporter (DAT1) mediates the active reuptake of dopamine from the synapses and thereby plays a key role in the regulation of the dopaminergic neurotransmission. In this study, we sought to determine the possible association of the DAT1 gene core promoter polymorphism-67A/T with schizophrenia in a case control study. Materials & Methods: The allele and genotype frequencies of the polymorphism were studied in 100 patients and 100 controls, which were matched on the basis of sex, age and ethnicity. Results: The genotype frequencies in the patients group were as follows: AA 29%, AT...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...
The genes for the dopamine transporter (DAT) and the D‐Amino acid oxidase activator (DAOA or G72) ha...
The gene encoding the dopamine transporter (DAT) has been implicated in CNS disorders, but the respo...
Dopamine transporter (DAT) gene variants do not appear to provide widespread contributions to the et...
Objective: A 40-bp variable number tandem repeat in the 3′-UTR of dopamine transporter gene (DAT1) h...
Aim: We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-meth...
The human dopamine transporter (DAT, SLC6A3) has been extensively investigated because of its potent...
The human dopamine transporter (DAT, SLC6A3) has been extensively investigated because of its potent...
We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ)....
Objective: Tardive dyskinesia (TD) is an antipsychotic induced side effect observed in 20-30% of sch...
The dopamine system has long been suspected of aetiological involvement in schizophrenia because of ...
Objective: Understanding the etiology and pathogenesis of schizophrenia has been difficult due to th...
Objective: Involvement of genetic factors in the pathogenesis of schizophrenia spectrum disorders ha...
The dopamine hypothesis of schizophrenia (SZ) has moti-vated a large number of genetic association s...
disorders has been indicated in twin, adoption, and familial aggregation studies; the pivotal role p...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...
The genes for the dopamine transporter (DAT) and the D‐Amino acid oxidase activator (DAOA or G72) ha...
The gene encoding the dopamine transporter (DAT) has been implicated in CNS disorders, but the respo...
Dopamine transporter (DAT) gene variants do not appear to provide widespread contributions to the et...
Objective: A 40-bp variable number tandem repeat in the 3′-UTR of dopamine transporter gene (DAT1) h...
Aim: We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-meth...
The human dopamine transporter (DAT, SLC6A3) has been extensively investigated because of its potent...
The human dopamine transporter (DAT, SLC6A3) has been extensively investigated because of its potent...
We evaluated the hypothesis that dopaminergic polymorphisms are risk factors for schizophrenia (SZ)....
Objective: Tardive dyskinesia (TD) is an antipsychotic induced side effect observed in 20-30% of sch...
The dopamine system has long been suspected of aetiological involvement in schizophrenia because of ...
Objective: Understanding the etiology and pathogenesis of schizophrenia has been difficult due to th...
Objective: Involvement of genetic factors in the pathogenesis of schizophrenia spectrum disorders ha...
The dopamine hypothesis of schizophrenia (SZ) has moti-vated a large number of genetic association s...
disorders has been indicated in twin, adoption, and familial aggregation studies; the pivotal role p...
Background: Being the primary target of antipsychotic therapy, dopamine receptor type 2 (DRD2) remai...
The genes for the dopamine transporter (DAT) and the D‐Amino acid oxidase activator (DAOA or G72) ha...
The gene encoding the dopamine transporter (DAT) has been implicated in CNS disorders, but the respo...